Enanta Pharmaceutica (ENTA)
$71.93
1.59 (2.26%)
ENTA Stock Quote Delayed 15 Minutes
Previous Close
$71.93
Market Cap
1.39B
PE Ratio
27.14
EPS
2.65
Volume (Avg. Vol.)
192,800
Day's Range
70.75 - 72.70
52-Week Range
64.08 - 106.80
Dividend & Yield
N/A (N/A)
ENTA Stock Predictions, Articles, and Enanta Pharmaceutica News
Why Enanta Stock Is Still a Strong Buy With Huge Upside
ENTA stock has had a tough time lately, but Enanta is making some big waves outside of the harsh headlines that shouldn't be ignored.
37 Biotechnology Stocks to Sell Now
This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Manufacturing Stocks Now – ENTA KTEC MOV MT
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
52 Biotechnology Stocks to Sell Now
The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
19 Biotechnology Stocks to Sell Now
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
41 Biotechnology Stocks to Sell Now
The overall ratings of 41 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
5 Stocks With Superb Earnings Momentum — KNSY PBF FTEK EVAC ENTA
This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Strong Earnings Momentum — KNSY PBF FTEK EVAC ENTA
This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.
10 Best “Strong Buy” Stocks — ALX ANIP SONC and more
This week, these ten stocks, all currently earning A's ("strong buy") on Portfolio Grader, have the best year-to-date performance.
13 Biotechnology Stocks to Buy Now
This week, 13 biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
5 Best Sectors to Watch This Week
This week, the commercial banking, aerospace and defense, life science, biotechnology and pharmaceutical sectors are gathering momentum on the Portfolio Grader database.
5 Stocks With Prime Sales Growth — ENTA MARA HTH INSY CREG
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Best Sectors to Watch This Week
The commercial banking, aerospace and defense, life science, biotechnology and pharmaceutical sectors are having a strong week, according to Portfolio Grader.
5 Stocks With Great Sales Growth — ENTA HTH INSY CREG TTWO
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
14 “Triple A” Stocks to Buy
This week, 14 stocks get A's ("strong buy") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade and Quantitative Grade.
5 Best Sectors to Watch This Week
This week, commercial banking, aerospace and defense, life science, biotechnology and pharmaceutical are the best sectors on the Portfolio Grader database.
5 Stocks With Superb Sales Growth — ENTA HTH INSY CREG TTWO
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
